ALFASIGMA SPA

ALFASIGMA SPA logo
🇮🇹Italy
Ownership
Holding
Established
2015-01-01
Employees
1K
Market Cap
-
Website
http://www.alfasigma.com

Study to Measure Filgotinib in the Blood of Children and Teenagers With Arthritis Taking Filgotinib (SCALESIA)

Phase 1
Recruiting
Conditions
Interventions
First Posted Date
2024-01-24
Last Posted Date
2024-10-16
Lead Sponsor
Alfasigma S.p.A.
Target Recruit Count
10
Registration Number
NCT06222034
Locations
🇫🇷

CHU Amiens - Hopital Nord, Amiens Cedex 1, France

🇩🇪

Children's university hospital Charité, Campus Virchow, SPZ, Berlin, Germany

🇫🇷

Bicêtre University Hospital, Le Kremlin Bicêtre, France

and more 6 locations

Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)

Recruiting
Conditions
Interventions
First Posted Date
2023-04-18
Last Posted Date
2024-12-16
Lead Sponsor
Alfasigma S.p.A.
Target Recruit Count
600
Registration Number
NCT05817942
Locations
🇩🇪

Synesis GmbH, Grünwald, Bavaria, Germany

🇪🇸

Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, Spain

🇦🇹

LKH - Universitätsklinikum Graz, Graz, Austria

and more 72 locations

A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis

Phase 3
Active, not recruiting
Conditions
Interventions
First Posted Date
2023-03-27
Last Posted Date
2024-12-17
Lead Sponsor
Alfasigma S.p.A.
Target Recruit Count
495
Registration Number
NCT05785611
Locations
🇧🇬

Medical Center Teodora, Ruse, Bulgaria

🇧🇪

Cliniques Universitaires de Bruxelles Hopital Erasme, Brussels, Belgium

🇧🇪

ReumaClinic, Genk, Belgium

and more 126 locations

Velusetrag for the Treatment of Chronic Intestinal Pseudo-Obstruction (CIPO).

Phase 2
Active, not recruiting
Conditions
Interventions
First Posted Date
2023-02-13
Last Posted Date
2023-02-13
Lead Sponsor
Alfasigma S.p.A.
Target Recruit Count
17
Registration Number
NCT05724069
Locations
🇧🇪

UZ Leuven Gasthuisberg Campus, Leuven, Belgium

🇮🇹

Policlinico S.Orsola-Malpighi, Bologna, Italy

🇮🇹

Aou Arcispedale Sant'Anna Di Cona, Cona, Italy

and more 1 locations

Prospective Observational Study of Filgotinib in Participants With Rheumatoid Arthritis in France

Active, not recruiting
Conditions
Interventions
First Posted Date
2022-04-12
Last Posted Date
2024-12-16
Lead Sponsor
Alfasigma S.p.A.
Target Recruit Count
155
Registration Number
NCT05323591
Locations
🇫🇷

CHU Amiens Picardie site Nord, Amiens, France

🇫🇷

CHU de Amiens Picardie, Amiens, France

🇫🇷

Hopital Avicenne AP-HP, Bobigny, France

and more 14 locations

Safety, Efficacy and Pharmacokinetics of Rifaximin in Patients With Moderate-to-severe Papulopustular Rosacea

Phase 2
Completed
Conditions
Interventions
First Posted Date
2021-12-09
Last Posted Date
2024-04-24
Lead Sponsor
Alfasigma S.p.A.
Target Recruit Count
216
Registration Number
NCT05150587
Locations
🇺🇸

Skin Care Research, Boca Raton, Florida, United States

🇺🇸

Metropolis Dermatology, Los Angeles, California, United States

🇺🇸

DelRicht Research, Tulsa, Oklahoma, United States

and more 32 locations

Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis

Active, not recruiting
Conditions
Interventions
First Posted Date
2021-05-04
Last Posted Date
2024-12-17
Lead Sponsor
Alfasigma S.p.A.
Target Recruit Count
1304
Registration Number
NCT04871919
Locations
🇳🇱

READE, Amsterdam, Netherlands

🇩🇪

Universitatsklinikum Dusseldorf, Düsseldorf, Germany

🇮🇹

AOU Policlinico Vittorio Emanuele-PO San Marco, Catania, Italy

and more 84 locations

Safety and Efficacy of Rifaximin in Patients With Papulopustular Rosacea and Positive Lactulose Breath Test

First Posted Date
2019-03-06
Last Posted Date
2019-03-11
Lead Sponsor
Alfasigma S.p.A.
Target Recruit Count
236
Registration Number
NCT03864978
Locations
🇮🇹

Azienda Ospedaliera Universitaria Federico II, Napoli, Italy

🇮🇹

Azienda Ospedaliera Santa Maria, Terni, Italy

🇮🇹

A.O.U. Città della Salute e della Scienza, Torino, Italy

and more 9 locations

A Multicentre Study on Rifaximin in Post-operative Endoscopic Crohn's Disease Recurrence Prevention

First Posted Date
2018-05-25
Last Posted Date
2021-09-27
Lead Sponsor
Alfasigma S.p.A.
Target Recruit Count
43
Registration Number
NCT03537157
Locations
🇮🇹

Humanitas Clinical Research Center, Rozzano, Italy

Rifaximin Delayed Release for the Prevention of Recurrent Acute Diverticulitis and Diverticular Complications.

First Posted Date
2018-03-19
Last Posted Date
2021-10-20
Lead Sponsor
Alfasigma S.p.A.
Target Recruit Count
193
Registration Number
NCT03469050
Locations
🇮🇹

AOU Cagliari - Policlinico Monserrato Gastroenterologia, Cagliari, Italy

🇩🇪

Medamed GmbH Studienambulanz Leipzig, Leipzig, Germany

🇫🇷

Centre Hospitalier Regional Universitaire Claude Huriez Service de Chirurgie Digestive et Générale, Lille, France

and more 61 locations
© Copyright 2024. All Rights Reserved by MedPath